
|Articles|August 1, 2001
- Pharmaceutical Technology-08-01-2001
- Volume 2001 Supplement
- Issue 2
Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies
Author(s)Shabbir T. Anik, PhD, Colin M. Minchom, PhD
Successfully taking a new chemical entity from proof-of-concept to commercialization requires the biopharmaceutical company to carefully evaluate a contract services provider's formulation department and ability to become a fully integrated supplier.
Advertisement
Articles in this issue
almost 25 years ago
Creating a Successful Partnership with a Contract Manufactureralmost 25 years ago
Outsourcing Outlookalmost 25 years ago
Creative Solutions in Client-CRO Relationshipsalmost 25 years ago
Third-Party Technology Transferalmost 25 years ago
The Squeeze in Contract Manufacturingalmost 25 years ago
Stakes Rise for Blown Batchesalmost 25 years ago
Partnerships in Drug DiscoveryAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
3
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5




